documents: FDA-2012-D-0307-0024

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2012-D-0307-0024 FDA FDA-2012-D-0307 Reference 38-FDA Transmissible Spongiform Encephalopathies Advisory Committee re Amendment to ‘‘Revised Preventive Measures To Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products; Guidance for Industry;’’ Draft Guidance for Industry; Availability Supporting & Related Material Background Material 2017-12-22T05:00:00Z 2017 12     2020-02-25T15:38:38Z   0 0 0900006482d5883d

Links from other tables